Dr. Francisco Nieves-Rivera’s presentation for his lecture on Long-Term Outcomes of Growth Hormone Treatment In Childhood is available here:
DISCLOSURE: The speaker wishes to disclose that he has received honorarium as speaker consultant from the following pharmaceutical companies: NovoNordisk, and Pfizer. Also has stocks at Insulet Corp., Exact Sciences Corp., and Mannkind Corp.